REFERENCES

  1. Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause. 2018;25(10):1069-1085.
  2. Shea AK, Wolfman W, Fortier M, Soares CN. Guideline No. 422c: Menopause: Mood, Sleep, and Cognition. Journal of Obstetrics and Gynaecology Canada. 2021;43(11):1316-1323.e1311.
  3. Freeman EW, Sammel MD, Boorman DW, Zhang R. Longitudinal Pattern of Depressive Symptoms Around Natural Menopause. JAMA Psychiatry. 2014;71(1):36-43.
  4. Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T. Symptoms of menopause — global prevalence, physiology and implications. Nature Reviews Endocrinology. 2018;14(4):199-215.
  5. Voedisch AJ, Dunsmoor-Su R, Kasirsky J. Menopause: A Global Perspective and Clinical Guide for Practice. Clinical Obstetrics and Gynecology. 2021;64(3):528-554(527).
  6. Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations. Journal of Women's Health. 2019;28(2):117-134.
  7. Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Leserman J, Girdler SS. Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition. Menopause (New York, NY). 2016;23(3):257-266.
  8. Bromberger JT, Epperson CN. Depression during and after the perimenopause: Impact of hormones, genetics, and environmental determinants of disease. Obstetrics and Gynecology Clinics. 2018;45(4):663-678.
  9. Stanzel KA, Hammarberg K, Fisher J. Experiences of menopause, self-management strategies for menopausal symptoms and perceptions of health care among immigrant women: a systematic review. Climacteric. 2018;21(2):101-110.
  10. Stanzel DKA, Hammarberg DK, Fisher PJ. Challenges in menopausal care of immigrant women. Maturitas. 2021;150:49-60.
  11. Blount JG. Communication with Women in the Menopause Transition. Springer; 2022.
  12. Aninye IO, Laitner MH, Chinnappan S, Society for Women's Health Research Menopause Working G. Menopause preparedness: perspectives for patient, provider, and policymaker consideration. Menopause (New York, NY). 2021;28(10):1186-1191.
  13. Maki PM, Kornstein SG, Joffe H, et al. CONSENSUS RECOMMENDATIONS. Menopause. 2018;25(10):1069.
  14. Coslov N. Women's Voices: The Lived Experience of the Path to Menopause. Springer; 2022.
  15. Arroll B, Goodyear-Smith F, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4):348-353.
  16. Stute P, Spyropoulou A, Karageorgiou V, et al. Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement. Maturitas. 2020;131:91-101.
  17. Jambukala A, Godbole M. Menopausal Syndrome: An Underdiagnosed Condition. Australasian Medical Journal 2013;6(4):236.
  18. Nappi RE, Particco M, Biglia N, et al. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey. Maturitas. 2016;91:74-80.
  19. NJAFP. A Family Physician’s Guide to Treating Depression in the Minority Patient. Data on File. 2014.
  20. Gibbs Z, Lee S, Kulkarni J. What factors determine whether a woman becomes depressed during the perimenopause? Archives of Women's Mental Health. 2012;15(5):323-332.

References - Monograph

  1. Deeks AA. Psychological aspects of menopause management. Best Pract Res Clin Endocrinol Metab. 2003;17(1):17-31. doi:10.1016/S1521-690X(02)00077-5
  2. Talaulikar V. Menopause transition: Physiology and symptoms. Best Pract Res Clin Obstet Gynaecol. 2022;81:3-7. doi:10.1016/j.bpobgyn.2022.03.003
  3. Goodman N, Cobin R, Ginzburg S, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause. Endocr Pract. 2011;17(6):1-25. doi:10.4158/EP.17.S6.1
  4. Kagan R, Kellogg-Spadt S, Parish SJ. Practical treatment considerations in the management of genitourinary syndrome of menopause. Drugs Aging. 2019;36(10):897-908. doi:10.1007/s40266-019-00700-w
  5. Parish SJ, Nappi RE, Krychman ML, Kellogg-Spadt S, Simon JA, Goldstein JA, Kingsberg SA. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health. 2013;5:437-447. doi:10.2147/IJWH.S44579
  6. Harper JC, Phillips S, Biswakarma R, et al. An online survey of perimenopausal women to determine their attitudes and knowledge of the menopause. Women's Health (Lond). 2022;18:17455057221106890. doi:10.1177/17455057221106890
  7. Dutton PJ, Rymer JM. Physiology of the menstrual cycle and changes in the perimenopause. In: Panay N, Briggs P, Kovacs G, eds. Managing the Menopause: 21st Century Solutions. Cambridge University Press; 2015:1-10.
  8. Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop + 10: Addressing the unfinished agenda of staging reproductive aging J Clin Endocrinol Metab. 2012;97(4):1159-1168. doi:10.1210/jc.2011-3362
  9. El Khoudary SR. Age at menopause onset and risk of cardiovascular disease around the world. Maturitas. 2020;141:33-38. doi:10.1016/j.maturitas.2020.06.007
  10. Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T. Symptoms of menopause — global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14(4):199-215. doi:10.1038/nrendo.2017.180
  11. Thasneem K, Kalarani IB, Jayaprasad P, Mohammed V, Veerabathiran R. Genes linked with early menopause and the pathogenesis of its associated diseases: a systematic review. Middle East Fertil Soc J. 2022;27(1):2. doi:10.1186/s43043-021-00093-0
  12. Eum KD, Weisskopf MG, Nie LH, Hu H, Korrick SA. Cumulative lead exposure and age at menopause in the Nurses' Health Study cohort. Environ Health Perspect. 2014;122(3):229-34. doi:10.1289/ehp.1206399
  13. Mishra GD, Pandeya N, Dobson AJ, et al. Early menarche, nulliparity and the risk for premature and early natural menopause. Hum Reprod. 2017;32(3):679-686. doi:10.1093/humrep/dew350
  14. Wang X, Ding N, Harlow SD, Randolph JF, Mukherjee B, Gold EB, Park SK. Urinary metals and metal mixtures and timing of natural menopause in midlife women: The Study of Women’s Health Across the Nation. Environ Int. 2021;157:106781. doi:10.1016/j.envint.2021.106781
  15. Popovic M, McNeill FE, Chettle DR, Webber CE, Lee CV, Kaye WE. Impact of occupational exposure on lead levels in women. Environ Health Perspect. 2005;113(4):478-484. doi:doi:10.1289/ehp.7386
  16. Forman MR, Mangini LD, Thelus-Jean R, Hayward MD. Life-course origins of the ages at menarche and menopause. Adolesc Health Med Ther. 2013;4:1-21. doi:10.2147/ahmt.S15946
  17. Namazi M, Sadeghi R, Behboodi Moghadam Z. Social determinants of health in menopause: an integrative review. Int J Womens Health. 2019;11:637-647. doi:10.2147/IJWH.S228594
  18. Velez MP, Alvarado BE, Rosendaal N, da Câmara SM, Belanger E, Richardson H, Pirkle CM. Age at natural menopause and physical functioning in postmenopausal women: the Canadian Longitudinal Study on Aging. Menopause. 2019;26(9):958-965. doi:10.1097/gme.0000000000001362
  19. Whitcomb BW, Purdue-Smithe AC, Szegda KL, et al. Cigarette smoking and risk of early natural menopause. Am J Epidemiol. 2017;187(4):696-704. doi:10.1093/aje/kwx292
  20. Zhu D, Chung H-F, Pandeya N, et al. Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies. PLoS Med. 2018;15(11)(e1002704). doi:10.1371/journal.pmed.1002704
  21. Paramsothy P, Harlow SD, Nan B, et al. Duration of the menopausal transition is longer in women with young age at onset: the multiethnic Study of Women's Health Across the Nation. Menopause. 2017;24(2):142-149. doi:10.1097/gme.0000000000000736
  22. Zhu D, Chung H-F, Dobson AJ, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. The Lancet Public Health. 2019;4(11):e553-e564. doi:10.1016/S2468-2667(19)30155-0
  23. Williams M, Richard-Davis G, Weickert A, Christensin L, Ward E, Schrager S. A review of African American women's experiences in menopause. Menopause. 2022;29(11):1331-1337. doi:10.1097/GME.0000000000002060
  24. Perlman B, Kulak D, Goldsmith LT, Weiss G. The etiology of menopause: not just ovarian dysfunction but also a role for the central nervous system. Global Reproductive Health. 2018;3(2)(e8). DOI: 10.1097/GRH.0000000000000008
  25. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health. 2006;96(7):1226-35. doi:10.2105/ajph.2005.066936
  26. Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause. 2014;21(9):924-32. doi:10.1097/gme.0000000000000196
  27. Green R, Santoro N. Menopausal symptoms and ethnicity: the Study of Women’s Health Across the Nation. Women's Health (Lond). 2009;5(2):127–133. doi:10.2217/17455057.5.2.127
  28. Avis NE, Crawford SL, Green R. Vasomotor symptoms across the menopause transition: Differences among women. Obstet Gynecol Clin North Am. 2018;45(4):629-640. doi:10.1016/j.ogc.2018.07.005
  29. Melby MK, Anderson D, Sievert LL, Obermeyer CM. Methods used in cross-cultural comparisons of vasomotor symptoms and their determinants. Maturitas. 2011/10/01/ 2011;70(2):110-119. doi:10.1016/j.maturitas.2011.07.010
  30. Dotlic J, Markovic N, Gazibara T. Patterns of smoking and menopause-specific quality of life: smoking duration matters more. Behav Med. 2021;49(1):1-11. doi:10.1080/08964289.2021.1958739
  31. Anderson DJ, Chung HF, Seib CA, et al. Obesity, smoking, and risk of vasomotor menopausal symptoms: a pooled analysis of eight cohort studies. Am J Obstet Gynecol. 2020;222(5):478.e1-478.e17. doi:10.1016/j.ajog.2019.10.103
  32. Greendale GA, Sternfeld B, Huang M, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5)doi:10.1172/jci.insight.124865
  33. Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, Villaseca P. Understanding weight gain at menopause. Climacteric. 2012;15(5):419-29. doi:10.3109/13697137.2012.707385
  34. Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women J Sex Med. 2009;6(8):2133-2142. doi:10.1111/j.1743-6109.2009.01335.x
  35. Nappi RE, Kokot-Kierepa M. Women's voices in the menopause: Results from an international survey on vaginal atrophy. Maturitas. 2010;67(3):233-238. doi:10.1016/j.maturitas.2010.08.001
  36. Mili N, Paschou SA, Armeni A, Georgopoulos N, Goulis DG, Lambrinoudaki I. Genitourinary syndrome of menopause: a systematic review on prevalence and treatment. Menopause. 2021;28(6):706-716. doi:10.1097/gme.0000000000001752
  37. Avis NE, Brockwell S, Colvin A. A universal menopausal syndrome? Am J Med. 2005;118(12, Supplement 2):37-46. doi:10.1016/j.amjmed.2005.09.057
  38. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004;61(1):62-70. doi:10.1001/archpsyc.61.1.62
  39. Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: Results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry. 2010;67(6):598-607. doi:10.1001/archgenpsychiatry.2010.55
  40. Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause. 2018;25(10):1069-1085. doi:10.1097/gme.0000000000001174
  41. Shea AK, Wolfman W, Fortier M, Soares CN. Guideline No. 422c: menopause: mood, sleep, and cognition. J Obstet Gynaecol Can. 2021/11/01/ 2021;43(11):1316-1323.e1. doi:10.1016/j.jogc.2021.08.009
  42. Freeman EW, Sammel MD, Boorman DW, Zhang R. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry. 2014;71(1):36-43. doi:10.1001/jamapsychiatry.2013.2819
  43. Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause. 2018;25(10):1069-1085. doi:10.1097/gme.0000000000001174
  44. Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. J Womens Health (Larchmt). 2019;28(2):117-134. doi:10.1089/jwh.2018.27099.mensocrec
  45. Freeman EW, Sammel MD, Lin H. Temporal associations of hot flashes and depression in the transition to menopause. Menopause. 2009;16(4):728-34. doi:10.1097/gme.0b013e3181967e16
  46. Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Leserman J, Girdler SS. Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition. Menopause. 2016;23(3):257-266. doi:10.1097/GME.0000000000000528
  47. Gordon JL, Peltier A, Grummisch JA, Tottenham LS. Estradiol fluctuation, sensitivity to stress, and depressive symptoms in the menopause transition: a pilot study. Front Psychol. 2019;10(1319)doi:10.3389/fpsyg.2019.01319
  48. Bromberger JT, Epperson CN. Depression during and after the perimenopause: Impact of hormones, genetics, and environmental determinants of disease. Obstet Gynecol Clin North Am. 2018;45(4):663-678. doi:10.1016/j.ogc.2018.07.007
  49. Bromberger JT, Kravitz HM. Mood and menopause: findings from the Study of Women's Health Across the Nation (SWAN) over 10 years. Obstet Gynecol Clin North Am. 2011;38(3):609-25. doi:10.1016/j.ogc.2011.05.011
  50. Gronewold J, Duman EE, Engel M, et al. Association between life events and later depression in the population-based Heinz Nixdorf Recall study-The role of sex and optimism. PLoS One. 2022;17(7):e0271716. doi:10.1371/journal.pone.0271716
  51. Hickey M, Schoenaker DAJM, Joffe H, Mishra GD. Depressive symptoms across the menopause transition: findings from a large population-based cohort study. Menopause. 2016;23(12):1287-1293. doi:10.1097/gme.0000000000000712
  52. Van Dole KB, DeVellis RF, Brown RD, Jonsson Funk ML, Gaynes BN, Williams RE. Evaluation of the Menopause-Specific Quality of Life Questionnaire: a factor-analytic approach. Menopause. 2012;19(2):211-215. doi:10.1097/gme.0b013e31822817f9
  53. Minkin MJ. Menopause: hormones, lifestyle, and optimizing aging. Obstet Gynecol Clin N Am. 2019;46(3):501–514. doi:10.1016/j.ogc.2019.04.00
  54. Cagnacci A, Venier M. The controversial history of hormone replacement therapy. Medicina (Kaunas). 2019;55(9)doi:10.3390/medicina55090602
  55. Wilson RA. Feminine Forever. M. Evans & Company; 1966.
  56. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the women's health initiative randomized controlled trial. JAMA. 2002;288(3):321-333. doi:10.1001/jama.288.3.321
  57. Fournier A, Mesrine S, Dossus L, Boutron-Ruault M-C, Clavel-Chapelon F, Chabbert-Buffet N. Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort. Breast Cancer Res Treat. 2014/06/01 2014;145(2):535-543. doi:10.1007/s10549-014-2934-6
  58. Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women's health initiative randomized clinical trials. JAMA. 2020;324(4):369-380. doi:10.1001/jama.2020.9482
  59. Shifren JL, Gass MLS, for the Nams Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014;21(10)doi:10.1097/GME.0000000000000319
  60. World Health Organization. Menopause. 2022. Accessed August 8, 2023. https://www.who.int/news-room/fact-sheets/detail/menopause
  61. Stanzel KA, Hammarberg K, Fisher J. Experiences of menopause, self-management strategies for menopausal symptoms and perceptions of health care among immigrant women: a systematic review. Climacteric. 2018/03/04 2018;21(2):101-110. doi:10.1080/13697137.2017.1421922
  62. Stanzel KA, Hammarberg K, Fisher J. Challenges in menopausal care of immigrant women. Maturitas. 2021/08/01/ 2021;150:49-60. doi:10.1016/j.maturitas.2021.05.008
  63. Blount JG. Communication with women in the menopause transition. Each Woman’s Menopause: An Evidence Based Resource: For Nurse Practitioners, Advanced Practice Nurses and Allied Health Professionals. Springer; 2022.
  64. Obermeyer CM. Menopause across cultures: a review of the evidence. Menopause. 2000;(3):184-192. doi:10.1097/00042192-200007030-00009
  65. Carolan M. Menopause: Irish women's voices. J Obstet Gynecol Neonatal Nurs. 2000;29(4):397-404. doi:10.1111/j.1552-6909.2000.tb02062.x
  66. Stewart DE. Menopause in highland Guatemala Mayan women. Maturitas. 2003;44(4):293-297. doi:10.1016/S0378-5122(03)00036-7
  67. Menopause Steering Committee. Menopause. In: Barrett TJ, ed. Trenton, NJ: NJAFP; 2022.
  68. Richard-Davis G, Wellons M. Racial and ethnic differences in the physiology and clinical symptoms of menopause. Semin Reprod Med. 2013;31(5):380-386. doi:10.1055/s-0033-1348897
  69. Newhouser LM, Maneval M, Rayalam K, Sabeeh G, Varela L. SSRIs vs. SNRIs for vasomotor symptoms of menopause. Am Fam Physician. 2022;105(4):430-431.